<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Electrical stimulation for gastroparesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Electrical stimulation for gastroparesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Electrical stimulation for gastroparesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William L Hasler, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nicholas J Talley, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Gastroparesis is defined as a delay in gastric emptying with associated nausea, vomiting, bloating, early satiety, and discomfort. In severe cases, nausea and vomiting may cause weight loss, dehydration, electrolyte disturbances, and malnutrition due to inadequate caloric and fluid intake.</p><p>Management of gastroparesis includes supportive measures (eg, hydration and nutrition), optimizing glycemic control in patients with diabetes mellitus, medications, and occasionally pyloric or surgical therapy. The limited efficacy of these options for severe gastroparesis has provided a rationale for development of novel approaches for treatment. Electrical stimuli can be delivered to the stomach as low-energy, high-frequency gastric electrical neurostimulation or high-energy, low-frequency gastric pacing. The former has emerging evidence of efficacy and is available for humanitarian treatment of refractory gastroparesis, while the latter is too bulky for implantation and is not clinically available.</p><p>This topic review will provide an overview of the methods of electrical stimulation of and their efficacy in treating gastroparesis. The pathophysiology, etiology, diagnosis, and treatment of gastroparesis are discussed separately. (See  <a class="medical medical_review" href="/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/2638.html" rel="external">"Pathogenesis of delayed gastric emptying"</a> and  <a class="medical medical_review" href="/d/html/2532.html" rel="external">"Treatment of gastroparesis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The emptying of gastric contents after a meal is controlled by motor and myoelectric activities of different gastric regions.</p><p class="bulletIndent1"><span class="glyph">●</span>The proximal stomach exhibits changes in tone after eating, which initially accommodates the ingested bolus and then, as digestion progresses, regulates delivery of food particles into the distal stomach [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The distal stomach exhibits a fed motor pattern consisting of phasic contractions that propagate from the gastric body to the pylorus at a maximal frequency of three cycles per minute (cpm). These grind and mix the food into a fine suspension [<a href="#rid2">2</a>].</p><p></p><p>Impairment of normal phasic motor activity in the distal stomach produces gastroparesis. The frequency and direction of this activity is regulated by the gastric slow wave, a rhythmic electrical oscillation, which is generated by interstitial cells of Cajal in the proximal gastric body, the "pacemaker" zone of the stomach [<a href="#rid3">3</a>]. The slow wave is ubiquitously present at a frequency of 3 cpm, regardless of the contractile state of the stomach. Phasic contractions are generated when the slow wave plateau potential increases in amplitude or when action potentials are stimulated by meal-induced neurohumoral activators [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H2494980956"><span class="h1">CANDIDATES FOR GASTRIC ELECTRICAL STIMULATION</span></p><p class="headingAnchor" id="H919057097"><span class="h2">Indications</span></p><p class="headingAnchor" id="H2256016193"><span class="h3">Refractory idiopathic and diabetic gastroparesis</span><span class="headingEndMark"> — </span>The gastric electrical neurostimulator (Enterra Therapy system) is not approved by the US Food and Drug Administration (FDA) for unrestricted marketing for treatment of gastroparesis but is approved as a humanitarian use device. Because of probable benefit rather than established effectiveness, the device has also received humanitarian device exemption approval for treatment of refractory diabetic and idiopathic gastroparesis, documented by objective measures of delayed gastric emptying. (See  <a class="medical medical_review" href="/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis", section on 'Scintigraphic gastric emptying'</a>.)</p><p class="headingAnchor" id="H3945791798"><span class="h3">Other</span><span class="headingEndMark"> — </span>Other potential compassionate use applications of gastric stimulation that have been evaluated in small series of patients with refractory symptoms include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroparesis due to other causes</strong> – Patients with refractory gastroparesis from other causes including postsurgical etiologies (after fundoplication for acid reflux, esophagectomy for esophageal carcinoma, bariatric surgery) and gastroparesis secondary to malignancy, chronic intestinal pseudo-obstruction, Crohn disease, or transplantation have undergone gastric stimulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Refractory cyclic vomiting syndrome</strong> – In one study of 11 patients with refractory cyclic vomiting syndrome, permanent gastric electrical stimulation was associated with a decrease in nausea and vomiting of 46 and 69 percent, respectively, compared with baseline [<a href="#rid5">5</a>]. </p><p></p><p class="headingAnchor" id="H273598570"><span class="h2">Relative contraindications</span><span class="headingEndMark"> — </span>There are no absolute contraindications to gastric neurostimulation. Due to the risk of postoperative infection, patients on immunosuppressive therapy may not be optimal candidates. Chronic opioid use adversely impacts the therapeutic response to gastric stimulation and should be considered when referring opioid-dependent patients for gastric stimulation [<a href="#rid6">6</a>]. Gastric neurostimulation should be avoided during pregnancy as the effects of stimulation on the developing fetus are unknown. </p><p class="headingAnchor" id="H2411802664"><span class="h2">Predictors of response</span><span class="headingEndMark"> — </span>Patients with diabetes are more likely than those with idiopathic disease to exhibit clinical improvement following stimulator surgery and show greater likelihood to remain on gastric stimulation long-term [<a href="#rid7">7-10</a>]. In a meta-analysis of 49 studies, clinical improvements with gastric stimulation were greater in patients with more severe initial symptoms [<a href="#rid11">11</a>].</p><p>Rates of gastric emptying generally do not predict responses to gastric stimulation. However, some studies noted better responses in those with more prolonged retention, while another found that more severe emptying delays predicted the need to perform stimulator implantation in diabetics but not idiopathic patients [<a href="#rid8">8,12,13</a>]. </p><p>Damage to myenteric ganglia and loss of interstitial cells of Cajal in the stomach have been reported as gastric histologic predictors of response to gastric stimulation [<a href="#rid14">14,15</a>]. Furthermore, the presence of gastric smooth muscle fibrosis is predictive of a worse response to gastric stimulation [<a href="#rid14">14</a>]. </p><p class="headingAnchor" id="H961921959"><span class="h1">HIGH-FREQUENCY GASTRIC ELECTRICAL STIMULATION</span></p><p class="headingAnchor" id="H2044925"><span class="h2">Mechanism of action</span><span class="headingEndMark"> — </span>The mechanism of action of high frequency (12 cpm) gastric neurostimulation may be multifactorial, but probably does not relate to stimulating gastric emptying as the stimuli are of insufficient amplitude to generate antral contractions. Consistent acceleration of emptying has not been observed in clinical trials [<a href="#rid16">16</a>]. Gastric neurostimulation also has no effect on basal gastric electrical activity and does not reverse slow wave dysrhythmias, but it can enhance slow-wave amplitude and propagation velocity [<a href="#rid17">17,18</a>]. Intraoperative high resolution measurements of gastric electrical conduction profiles have shown no effects of gastric neurostimulation on slow wave dysrhythmias, conduction blocks, retrograde propagation, ectopic pacemakers, or colliding waveforms [<a href="#rid19">19</a>]. The device increases maximally tolerated volumes of gastric distention, reflecting blunting of luminal perception [<a href="#rid20">20</a>]. Gastric neurostimulation modifies sympathovagal activity and modulates activity in thoracic spinal neurons that are responsive to gastric distention, however, autonomic benefits only become evident months after implantation, suggesting they are not critical for symptom improvements [<a href="#rid21">21-23</a>].</p><p>In animal models, gastric neurostimulation increases ghrelin-positive cells and plasma ghrelin levels, suggesting possible mechanistic participation of this neurohumoral agent [<a href="#rid24">24</a>]. Reductions in serum tumor necrosis factor-alpha levels after surgery may indicate additional anti-inflammatory effects of gastric neurostimulation [<a href="#rid25">25</a>]. In diabetic rats, gastric stimulation enhances interstitial cell of Cajal proliferation and increases enteric nerve populations responsible for nitric oxide and acetylcholine transmission [<a href="#rid26">26</a>]. </p><p class="headingAnchor" id="H3218616147"><span class="h2">Technique</span></p><p class="headingAnchor" id="H2968766119"><span class="h3">Permanent stimulator</span><span class="headingEndMark"> — </span>The gastric neurostimulator can be implanted via laparoscopy or laparotomy. The device consists of a pair of leads, a pulse generator, and a programming system. The leads are placed in the muscularis propria of the greater curvature of the stomach, 10 cm proximal to the pylorus and are connected to a pulse generator. The pulse generator is typically placed subcutaneously in the right or left upper quadrants of the abdomen. An external programming device controls the stimulation parameters. The battery life is typically 5 to 10 years, but this duration can vary depending on the energy level settings. </p><p class="headingAnchor" id="H4207262688"><span class="h3">Temporary stimulator</span><span class="headingEndMark"> — </span>Endoscopically placed temporary stimulating electrodes are employed by some centers of expertise to help predict who might respond to a permanently implanted device [<a href="#rid27">27</a>]. </p><p class="headingAnchor" id="H591275"><span class="h2">Benefits</span></p><p class="headingAnchor" id="H1948887014"><span class="h3">Clinical outcomes in uncontrolled reports</span><span class="headingEndMark"> — </span>Response rates to gastric neurostimulation in uncontrolled studies range from 50 to 92 percent, which can persist for up to 15 years [<a href="#rid28">28-30</a>]. In a systematic review of 19 studies of gastric stimulation for gastroparesis, nausea and vomiting were more likely to improve than abdominal pain [<a href="#rid6">6,31,32</a>]. Symptomatic improvement has been reported as soon as three days after device implantation [<a href="#rid5">5,6,33-39</a>]. In an analysis of a large multicenter cohort using propensity score methods, nausea improved to greater degrees among 81 patients who underwent gastric stimulator surgery versus 238 patients who did not [<a href="#rid40">40</a>]. In contrast, gastric stimulation has not consistently demonstrated improvements in other gastrointestinal symptoms including fullness, bloating, or acid reflux symptoms [<a href="#rid6">6,9</a>].</p><p>Additional studies have reported associated improvements with gastric stimulation in body mass index, HbA1c, serum albumin, and reduction in the need for prokinetic medication and supplemental nutrition [<a href="#rid34">34,37,41,42</a>]. Gastric stimulation has also been associated with improvements in physical and mental quality-of-life scores and reduction in hospitalizations [<a href="#rid34">34,36,41</a>]. (See  <a class="medical medical_review" href="/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H144012837"><span class="h3">Efficacy compared with other treatments</span><span class="headingEndMark"> — </span>A systematic review of 38 studies reported smaller improvements in nausea and abdominal pain with gastric neurostimulation compared with pyloromyotomy or pyloroplasty and lesser antiemetic effects than observed after pyloric surgery or gastrectomy [<a href="#rid31">31</a>]. Similarly, responses to gastric stimulation were less than with gastric peroral endoscopic myotomy of the pylorus in a study [<a href="#rid43">43</a>]. However, another paper observed comparable benefits of gastric stimulation and pyloric therapies in 82 patients with refractory gastroparesis [<a href="#rid44">44</a>]. Superior long-term outcomes were seen after total gastrectomy versus gastric stimulation in one study, but this outcome may have been influenced by a higher prevalence of postsurgical gastroparesis in the gastrectomy group [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H4273099098"><span class="h2">Sham-controlled trials of gastric stimulation</span><span class="headingEndMark"> — </span>In three initial randomized crossover trials, there was only marginal benefit of gastric stimulation compared to sham stimulation treatment arms where no electrical current was delivered [<a href="#rid46">46-48</a>]. However, a sham-controlled study observed significant symptom decreases with active stimulation, which were associated with reduced health care utilization [<a href="#rid49">49,50</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>The first suggested that there was benefit only in diabetic patients with active gastric stimulation versus sham treatment, while patients with idiopathic benefits showed no symptom reductions [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The second study in diabetic gastroparesis showed no difference in symptoms during the blinded treatment phase whether the device was turned on or off [<a href="#rid47">47</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A third controlled study in idiopathic gastroparesis patients had a similar trial design as the investigation in diabetics and results paralleled the diabetic study, showing no significant differences in symptoms in the blinded crossover phase regardless of whether the device was on or off [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter randomized trial in which 149 patients with gastroparesis were assigned to on (active) versus off (sham) stimulation for four months with crossover to the other arm for an additional four months, vomiting scores were significantly improved with the device on versus off in both diabetic and nondiabetic patients [<a href="#rid49">49</a>]. However, no other symptom benefits were reported in this study. In additional analyses from this trial, active stimulation was associated with reductions in hospitalizations, lower health care costs, and less work absenteeism [<a href="#rid50">50</a>]. </p><p></p><p class="headingAnchor" id="H591135"><span class="h2">Risks</span><span class="headingEndMark"> — </span>Risks of high-frequency gastric neurostimulation include infection, lead migration or erosion or dislodgement, electrode penetration into the gastric mucosa, seroma, and bowel obstruction. </p><p>Reasons for device explantation in one series included nonresponse to therapy (4 percent), mechanical issues (3 percent), and infection (2 percent) [<a href="#rid51">51</a>]. Battery replacement is often required within 10 years of initial device implantation [<a href="#rid28">28</a>]. Forty-three percent of patients in one longitudinal study required an average of 2.15 additional surgeries over eight years of follow-up, mostly for battery exchange and device relocation [<a href="#rid30">30</a>]. </p><p class="headingAnchor" id="H1258089647"><span class="h2">Management of treatment failures</span><span class="headingEndMark"> — </span>In patients who fail to respond to gastric stimulation or who develop recurrent symptoms after surgery, additional treatment options include pyloric myotomy or replacement of the gastric stimulator.  </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pyloric myotomy</strong> – In patients with a poor response to gastric neurostimulation, addition of pyloroplasty may improve symptoms. In one study, addition of pyloroplasty to gastric stimulation promoted greater acceleration of gastric emptying compared with stimulator implantation alone with greater symptom improvements [<a href="#rid52">52</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Replacement of gastric electrical stimulator</strong> – In patients initially unresponsive to gastric electrical stimulation, implanting a replacement stimulator with positioning of the new electrodes to alternate locations on the gastric serosa has been associated with reduced symptoms [<a href="#rid53">53</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h1">OTHER INVESTIGATIONAL MODES OF ELECTRICAL STIMULATION</span></p><p class="headingAnchor" id="H4104205849"><span class="h2">Newer experimental methods of gastric neurostimulation</span><span class="headingEndMark"> — </span>New approaches to gastric neurostimulation are in development. Progress in nonoperative methods of electrode insertion, device miniaturization, and battery technology may expand the options available for these patients. A percutaneous electrode system was developed to deliver neurostimulating pulses for up to eight weeks in patients with gastroparesis [<a href="#rid54">54</a>]. With this technique, a cannula with an internal needle is introduced percutaneously and advanced to the gastric submucosa. A self-anchoring electrode is then placed through the needle. Electrodes that can be placed during percutaneous gastrostomy placement have also been devised [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H2705428597"><span class="h2">High-energy, low-frequency gastric pacing</span><span class="headingEndMark"> — </span>Gastric pacing differs from gastric neurostimulation in that it resets the regular slow wave rhythm by delivering low duration electrical pulses (30 to 500 ms) and promotes increased gastric contractions with a consequence of accelerating gastric emptying. In an open-label trial of gastric pacing, nine gastroparesis patients received high-energy, long-duration electrical pulses at a rate slightly higher than the normal slow wave frequency through surgically implanted electrodes [<a href="#rid56">56</a>]. When delivered before and after meals, the pacing stimuli entrained the slow wave in all individuals and corrected any underlying slow wave rhythm disturbances. After one month, gastroparetic symptoms decreased, eight patients no longer required jejunal tube feedings, and gastric emptying was enhanced. Multichannel stimulation protocols have been devised to deliver high-energy pulses in sequential fashion that evoke propagating contractions and enhance gastric emptying with lower current requirements [<a href="#rid57">57</a>]. Two-channel pacing with reduced current requirements has shown efficacy in stimulating gastric emptying and reducing symptoms in patients with severe diabetic gastroparesis [<a href="#rid58">58</a>]. A feedback-controlled mechanism that can turn the pacer on or off depending on the intrinsic contractile state of the stomach has been developed [<a href="#rid59">59</a>]. Such devices that are activated only when triggered may reduce current requirements and prolong battery life. Despite these advances, gastric pacing remains impractical because the external current source needed to generate the energy to entrain the slow wave is too large for subcutaneous implantation. </p><p>Research into newer gastric pacing methods is focusing on portable implantable devices that do not require permanent externally-wired connections. Endoscopically-delivered miniaturized stimulators that can be affixed to or implanted in the gastric mucosa have been developed that enhance slow wave regularity and amplitudes [<a href="#rid60">60,61</a>]. An investigational battery-powered gastric pacemaker combined with high-resolution electrical mapping, which is activated in wireless fashion by a mobile phone or computer was shown to entrain slow waves in a porcine model [<a href="#rid62">62</a>]. Other methods that have been shown to entrain and enhance slow wave activity include a leadless inductively powered pacemaker implanted in the gastric serosa in a pig model, which is activated by an external transmitter, and a similar implantable magnet system in the gastric wall with an external drive coil [<a href="#rid63">63,64</a>]. </p><p>Another area of investigation relates to devices that deliver dual stimuli, which elicit beneficial effects both on symptoms and gastric emptying by combining effective features of both neurostimulation and pacing. In canine studies, stimulation with low-energy pulses of short duration alternating with high-energy pulses of long duration exerted antiemetic effects and reversed slow wave dysrhythmias caused by the emetic stimulus vasopressin [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H1027374569"><span class="h2">Extragastric electrical stimulation</span><span class="headingEndMark"> — </span>Studies suggest that electrical stimulation at sites distant from the stomach may provide symptom benefits in gastroparesis. Transcutaneous vagal nerve stimulators, like those used for migraine treatment, have improved symptoms in some uncontrolled gastroparesis studies [<a href="#rid66">66</a>]. A noninvasive thoracic spinal nerve magnetic neuromodulator treatment reduced symptoms in seven patients with diabetic gastroparesis in a proof-of-concept report [<a href="#rid67">67</a>].  </p><p class="headingAnchor" id="H3505763577"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117173.html" rel="external">"Society guideline links: Gastroparesis"</a>.)</p><p class="headingAnchor" id="H9577030"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Electrical stimuli can be delivered to the stomach as low-energy, high-frequency gastric neurostimulation or high-energy, low-frequency gastric pacing. (See <a class="local">'Introduction'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastric neurostimulation has no effect on basal gastric emptying or electrical activity but modifies sympathovagal activity and perception of gastric distention. Uncontrolled studies suggest clinically important benefits of gastric neurostimulation, including improvements in nausea and vomiting associated with gastroparesis. Emerging evidence from a multicenter crossover trial suggests there may be benefit from active versus sham stimulation. (See <a class="local">'Mechanism of action'</a> above and <a class="local">'Benefits'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with severe nausea and vomiting refractory to antiemetic and prokinetic drug therapy for at least one year may be candidates for gastric stimulation. In the United States, the gastric neurostimulator (Enterra Therapy system) is approved as a humanitarian exemption device only for diabetic and idiopathic gastroparesis. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The benefits of gastric neurostimulation for symptoms other than nausea and vomiting are uncertain. Patients with nausea and vomiting and those without narcotic dependence have more favorable clinical responses than those with predominant abdominal pain, bloating, or fullness. Patients with diabetic gastroparesis have greater symptom reductions versus individuals with idiopathic or postsurgical disease. (See <a class="local">'Predictors of response'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risks of gastric neurostimulation include infection, lead migration or erosion, lead dislodgement, electrode penetration into the gastric mucosa requiring re-operation, seroma, and bowel obstruction. (See <a class="local">'Risks'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Progress in device miniaturization, battery technology, devices that deliver variable stimuli, and remote leadless delivery may offer greater options for electrical neurostimulation and pacing of the stomach for refractory gastroparesis in the future. Studies describing symptom reductions with vagal or spinal stimulation methods suggest potential benefits of extragastric electrical protocols as well. (See <a class="local">'Other investigational modes of electrical stimulation'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Collins PJ, Horowitz M, Chatterton BE. Proximal, distal and total stomach emptying of a digestible solid meal in normal subjects. Br J Radiol 1988; 61:12.</a></li><li><a class="nounderline abstract_t">Rees WD, Go VL, Malagelada JR. Antroduodenal motor response to solid-liquid and homogenized meals. Gastroenterology 1979; 76:1438.</a></li><li><a class="nounderline abstract_t">Hinder RA, Kelly KA. Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg 1977; 133:29.</a></li><li><a class="nounderline abstract_t">Morgan KG, Szurszewski JH. Mechanisms of phasic and tonic actions of pentagastrin on canine gastric smooth muscle. J Physiol 1980; 301:229.</a></li><li><a class="nounderline abstract_t">Grover I, Kim R, Spree DC, et al. Gastric Electrical Stimulation Is an Option for Patients with Refractory Cyclic Vomiting Syndrome. J Neurogastroenterol Motil 2016; 22:643.</a></li><li><a class="nounderline abstract_t">Maranki JL, Lytes V, Meilahn JE, et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci 2008; 53:2072.</a></li><li><a class="nounderline abstract_t">Hou Q, Lin Z, Mayo MS, et al. Is symptom relief associated with reduction in gastric retention after gastric electrical stimulation treatment in patients with gastroparesis? A sensitivity analysis with logistic regression models. Neurogastroenterol Motil 2012; 24:639.</a></li><li><a class="nounderline abstract_t">Richmond B, Chong B, Modak A, et al. Gastric electrical stimulation for refractory gastroparesis: predictors of response and redefining a successful outcome. Am Surg 2015; 81:467.</a></li><li><a class="nounderline abstract_t">Heckert J, Sankineni A, Hughes WB, et al. Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center. Dig Dis Sci 2016; 61:168.</a></li><li><a class="nounderline abstract_t">Kim D, Gedney R, Allen S, et al. Does etiology of gastroparesis determine clinical outcomes in gastric electrical stimulation treatment of gastroparesis? Surg Endosc 2021; 35:4550.</a></li><li><a class="nounderline abstract_t">Levinthal DJ, Bielefeldt K. Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis. Auton Neurosci 2017; 202:45.</a></li><li><a class="nounderline abstract_t">O'Loughlin PM, Gilliam AD, Shaban F, Varma JS. Pre-operative gastric emptying time correlates with clinical response to gastric electrical stimulation in the treatment of gastroparesis. Surgeon 2013; 11:134.</a></li><li><a class="nounderline abstract_t">Hejazi RA, Sarosiek I, Roeser K, McCallum RW. Does grading the severity of gastroparesis based on scintigraphic gastric emptying predict the treatment outcome of patients with gastroparesis? Dig Dis Sci 2011; 56:1147.</a></li><li><a class="nounderline abstract_t">Heckert J, Thomas RM, Parkman HP. Gastric neuromuscular histology in patients with refractory gastroparesis: Relationships to etiology, gastric emptying, and response to gastric electric stimulation. Neurogastroenterol Motil 2017; 29.</a></li><li><a class="nounderline abstract_t">Omer E, Kedar A, Nagarajarao HS, et al. Cajal Cell Counts are Important Predictors of Outcomes in Drug Refractory Gastroparesis Patients With Neurostimulation. J Clin Gastroenterol 2019; 53:366.</a></li><li><a class="nounderline abstract_t">Lin Z, Hou Q, Sarosiek I, et al. Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation. Neurogastroenterol Motil 2008; 20:464.</a></li><li><a class="nounderline abstract_t">Xing J, Brody F, Rosen M, et al. The effect of gastric electrical stimulation on canine gastric slow waves. Am J Physiol Gastrointest Liver Physiol 2003; 284:G956.</a></li><li><a class="nounderline abstract_t">Lin Z, Forster J, Sarosiek I, McCallum RW. Effect of high-frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patients. Neurogastroenterol Motil 2004; 16:205.</a></li><li><a class="nounderline abstract_t">Angeli TR, Du P, Midgley D, et al. Acute Slow Wave Responses to High-Frequency Gastric Electrical Stimulation in Patients With Gastroparesis Defined by High-Resolution Mapping. Neuromodulation 2016; 19:864.</a></li><li><a class="nounderline abstract_t">Gourcerol G, Ouelaa W, Huet E, et al. Gastric electrical stimulation increases the discomfort threshold to gastric distension. Eur J Gastroenterol Hepatol 2013; 25:213.</a></li><li><a class="nounderline abstract_t">McCallum RW, Dusing RW, Sarosiek I, et al. Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients. Conf Proc IEEE Eng Med Biol Soc 2006; 1:5400.</a></li><li><a class="nounderline abstract_t">Qin C, Chen JD, Zhang J, Foreman RD. Modulatory effects and afferent pathways of gastric electrical stimulation on rat thoracic spinal neurons receiving input from the stomach. Neurosci Res 2007; 57:29.</a></li><li><a class="nounderline abstract_t">Liu J, Qiao X, Chen JD. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci 2004; 49:729.</a></li><li><a class="nounderline abstract_t">Gallas S, Sinno MH, Boukhettala N, et al. Gastric electrical stimulation increases ghrelin production and inhibits catecholaminergic brainstem neurons in rats. Eur J Neurosci 2011; 33:276.</a></li><li><a class="nounderline abstract_t">Abell TL, Kedar A, Stocker A, et al. Gastroparesis syndromes: Response to electrical stimulation. Neurogastroenterol Motil 2019; 31:e13534.</a></li><li><a class="nounderline abstract_t">Chen Y, Zhang S, Li Y, et al. Gastric Electrical Stimulation Increases the Proliferation of Interstitial Cells of Cajal and Alters the Enteric Nervous System in Diabetic Rats. Neuromodulation 2022; 25:1106.</a></li><li><a class="nounderline abstract_t">Abell TL, Johnson WD, Kedar A, et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc 2011; 74:496.</a></li><li><a class="nounderline abstract_t">Anand C, Al-Juburi A, Familoni B, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion 2007; 75:83.</a></li><li><a class="nounderline abstract_t">McCallum RW, Lin Z, Forster J, et al. Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol 2011; 9:314.</a></li><li><a class="nounderline abstract_t">Brody F, Zettervall SL, Richards NG, et al. Follow-up after gastric electrical stimulation for gastroparesis. J Am Coll Surg 2015; 220:57.</a></li><li><a class="nounderline abstract_t">Zoll B, Zhao H, Edwards MA, et al. Outcomes of surgical intervention for refractory gastroparesis: a systematic review. J Surg Res 2018; 231:263.</a></li><li><a class="nounderline abstract_t">Lahr CJ, Griffith J, Subramony C, et al. Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis. Am Surg 2013; 79:457.</a></li><li><a class="nounderline abstract_t">Abell TL, Van Cutsem E, Abrahamsson H, et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002; 66:204.</a></li><li><a class="nounderline abstract_t">Forster J, Sarosiek I, Lin Z, et al. Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg 2003; 186:690.</a></li><li><a class="nounderline abstract_t">Cutts TF, Luo J, Starkebaum W, et al. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil 2005; 17:35.</a></li><li><a class="nounderline abstract_t">Lin Z, McElhinney C, Sarosiek I, et al. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci 2005; 50:1328.</a></li><li><a class="nounderline abstract_t">Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006; 18:18.</a></li><li><a class="nounderline abstract_t">Andersson S, Lönroth H, Simrén M, et al. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction. Neurogastroenterol Motil 2006; 18:823.</a></li><li><a class="nounderline abstract_t">Jayanthi NV, Dexter SP, Sarela AI, Leeds Gastroparesis Multi-Disciplinary Team. Gastric electrical stimulation for treatment of clinically severe gastroparesis. J Minim Access Surg 2013; 9:163.</a></li><li><a class="nounderline abstract_t">Abell TL, Yamada G, McCallum RW, et al. Effectiveness of gastric electrical stimulation in gastroparesis: Results from a large prospectively collected database of national gastroparesis registries. Neurogastroenterol Motil 2019; 31:e13714.</a></li><li><a class="nounderline abstract_t">Abell T, Lou J, Tabbaa M, et al. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr 2003; 27:277.</a></li><li><a class="nounderline abstract_t">van der Voort IR, Becker JC, Dietl KH, et al. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes 2005; 113:38.</a></li><li><a class="nounderline abstract_t">Shen S, Luo H, Vachaparambil C, et al. Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes. Endoscopy 2020; 52:349.</a></li><li><a class="nounderline abstract_t">Marowski S, Xu Y, Greenberg JA, et al. Both gastric electrical stimulation and pyloric surgery offer long-term symptom improvement in patients with gastroparesis. Surg Endosc 2021; 35:4794.</a></li><li><a class="nounderline abstract_t">Samaan JS, Toubat O, Alicuben ET, et al. Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis. Surg Endosc 2022; 36:7561.</a></li><li><a class="nounderline abstract_t">Abell T, McCallum R, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125:421.</a></li><li><a class="nounderline abstract_t">McCallum RW, Snape W, Brody F, et al. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8:947.</a></li><li><a class="nounderline abstract_t">McCallum RW, Sarosiek I, Parkman HP, et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil 2013; 25:815.</a></li><li><a class="nounderline abstract_t">Ducrotte P, Coffin B, Bonaz B, et al. Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial. Gastroenterology 2020; 158:506.</a></li><li><a class="nounderline abstract_t">Gourcerol G, Coffin B, Bonaz B, et al. Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study. Clin Gastroenterol Hepatol 2022; 20:1857.</a></li><li><a class="nounderline abstract_t">Keller DS, Parkman HP, Boucek DO, et al. Surgical outcomes after gastric electric stimulator placement for refractory gastroparesis. J Gastrointest Surg 2013; 17:620.</a></li><li><a class="nounderline abstract_t">Sarosiek I, Forster J, Lin Z, et al. The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis. Neurogastroenterol Motil 2013; 25:134.</a></li><li><a class="nounderline abstract_t">Harrison NS, Williams PA, Walker MR, et al. Evaluation and treatment of gastric stimulator failure in patients with gastroparesis. Surg Innov 2014; 21:244.</a></li><li><a class="nounderline abstract_t">Abrahamsson H, Lönroth H, Simrén M. Progress in gastric electrical stimulation. Gastrointest Endosc 2008; 67:1209.</a></li><li><a class="nounderline abstract_t">Sallam HS, Chen JD, Pasricha PJ. Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc 2008; 68:754.</a></li><li><a class="nounderline abstract_t">McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114:456.</a></li><li><a class="nounderline abstract_t">Chen JD, Xu X, Zhang J, et al. Efficiency and efficacy of multi-channel gastric electrical stimulation. Neurogastroenterol Motil 2005; 17:878.</a></li><li><a class="nounderline abstract_t">Lin Z, Sarosiek I, Forster J, et al. Two-channel gastric pacing in patients with diabetic gastroparesis. Neurogastroenterol Motil 2011; 23:912.</a></li><li><a class="nounderline abstract_t">Arriagada AJ, Jurkov AS, Neshev E, et al. Design, implementation and testing of an implantable impedance-based feedback-controlled neural gastric stimulator. Physiol Meas 2011; 32:1103.</a></li><li><a class="nounderline abstract_t">Deb S, Tang SJ, Abell TL, et al. Development of innovative techniques for the endoscopic implantation and securing of a novel, wireless, miniature gastrostimulator (with videos). Gastrointest Endosc 2012; 76:179.</a></li><li><a class="nounderline abstract_t">Brum G, Fitts R, Pizarro G, Ríos E. Voltage sensors of the frog skeletal muscle membrane require calcium to function in excitation-contraction coupling. J Physiol 1988; 398:475.</a></li><li><a class="nounderline abstract_t">Alighaleh S, Cheng LK, Angeli TR, et al. A Novel Gastric Pacing Device to Modulate Slow Waves and Assessment by High-Resolution Mapping. IEEE Trans Biomed Eng 2019; 66:2823.</a></li><li><a class="nounderline abstract_t">Perley A, Roustaei M, Aguilar-Rivera M, et al. Miniaturized wireless gastric pacing via inductive power transfer with non-invasive monitoring using cutaneous Electrogastrography. Bioelectron Med 2021; 7:12.</a></li><li><a class="nounderline abstract_t">Prospero AG, Pinto LA, Matos RVR, et al. New device for active gastric mechanical stimulation. Neurogastroenterol Motil 2021; 33:e14169.</a></li><li><a class="nounderline abstract_t">Song GQ, Hou X, Yang B, et al. A novel method of 2-channel dual-pulse gastric electrical stimulation improves solid gastric emptying in dogs. Surgery 2008; 143:72.</a></li><li><a class="nounderline abstract_t">Gottfried-Blackmore A, Adler EP, Fernandez-Becker N, et al. Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis. Neurogastroenterol Motil 2020; 32:e13769.</a></li><li><a class="nounderline abstract_t">Karunaratne T, Yan Y, Eubanks A, et al. Thoracic Spinal Nerve Neuromodulation Therapy for Diabetic Gastroparesis: A Proof-of-Concept Study. Clin Gastroenterol Hepatol 2023; 21:2958.</a></li></ol></div><div id="topicVersionRevision">Topic 2578 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3349238" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Proximal, distal and total stomach emptying of a digestible solid meal in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/437442" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Antroduodenal motor response to solid-liquid and homogenized meals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/835775" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7411429" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mechanisms of phasic and tonic actions of pentagastrin on canine gastric smooth muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27241799" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Gastric Electrical Stimulation Is an Option for Patients with Refractory Cyclic Vomiting Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18080765" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22497770" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Is symptom relief associated with reduction in gastric retention after gastric electrical stimulation treatment in patients with gastroparesis? A sensitivity analysis with logistic regression models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25975330" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Gastric electrical stimulation for refractory gastroparesis: predictors of response and redefining a successful outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26280084" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32909214" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Does etiology of gastroparesis determine clinical outcomes in gastric electrical stimulation treatment of gastroparesis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27085627" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23206591" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pre-operative gastric emptying time correlates with clinical response to gastric electrical stimulation in the treatment of gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21113801" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Does grading the severity of gastroparesis based on scintigraphic gastric emptying predict the treatment outcome of patients with gastroparesis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28374487" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Gastric neuromuscular histology in patients with refractory gastroparesis: Relationships to etiology, gastric emptying, and response to gastric electric stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29672439" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cajal Cell Counts are Important Predictors of Outcomes in Drug Refractory Gastroparesis Patients With Neurostimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18086205" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12584109" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The effect of gastric electrical stimulation on canine gastric slow waves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15086874" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effect of high-frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27284964" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Acute Slow Wave Responses to High-Frequency Gastric Electrical Stimulation in Patients With Gastroparesis Defined by High-Resolution Mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23075698" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gastric electrical stimulation increases the discomfort threshold to gastric distension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17945898" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17046091" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Modulatory effects and afferent pathways of gastric electrical stimulation on rat thoracic spinal neurons receiving input from the stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15259491" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Vagal afferent is involved in short-pulse gastric electrical stimulation in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21059113" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gastric electrical stimulation increases ghrelin production and inhibits catecholaminergic brainstem neurons in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30706646" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Gastroparesis syndromes: Response to electrical stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35088751" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Gastric Electrical Stimulation Increases the Proliferation of Interstitial Cells of Cajal and Alters the Enteric Nervous System in Diabetic Rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21872708" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17519527" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21185396" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25458798" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Follow-up after gastric electrical stimulation for gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30278939" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Outcomes of surgical intervention for refractory gastroparesis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635579" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12592096" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gastric electrical stimulation in intractable symptomatic gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14672781" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Further experience with gastric stimulation to treat drug refractory gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15670262" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16047482" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371079" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16918761" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24250062" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Gastric electrical stimulation for treatment of clinically severe gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31584238" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effectiveness of gastric electrical stimulation in gastroparesis: Results from a large prospectively collected database of national gastroparesis registries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12903891" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15662594" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32084672" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33025250" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Both gastric electrical stimulation and pyloric surgery offer long-term symptom improvement in patients with gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35338403" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12891544" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Gastric electrical stimulation for medically refractory gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538073" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23895180" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31647902" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33189854" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23358845" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Surgical outcomes after gastric electric stimulator placement for refractory gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23113904" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24056201" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Evaluation and treatment of gastric stimulator failure in patients with gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18513561" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Progress in gastric electrical stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18718585" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9496935" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Gastric pacing improves emptying and symptoms in patients with gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16336504" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Efficiency and efficacy of multi-channel gastric electrical stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21806741" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Two-channel gastric pacing in patients with diabetic gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21693794" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Design, implementation and testing of an implantable impedance-based feedback-controlled neural gastric stimulator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22726478" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Development of innovative techniques for the endoscopic implantation and securing of a novel, wireless, miniature gastrostimulator (with videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3260626" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Voltage sensors of the frog skeletal muscle membrane require calcium to function in excitation-contraction coupling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30735980" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A Novel Gastric Pacing Device to Modulate Slow Waves and Assessment by High-Resolution Mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34425917" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Miniaturized wireless gastric pacing via inductive power transfer with non-invasive monitoring using cutaneous Electrogastrography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33969918" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : New device for active gastric mechanical stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18154935" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A novel method of 2-channel dual-pulse gastric electrical stimulation improves solid gastric emptying in dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31802596" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36152902" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Thoracic Spinal Nerve Neuromodulation Therapy for Diabetic Gastroparesis: A Proof-of-Concept Study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
